Adaptive immune cells in calcific aortic valve disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Calcific aortic valve disease (CAVD) is highly prevalent and has no pharmaceutical treatment. Surgical replacement of the aortic valve has proved effective in advanced disease but is costly, time limited, and in many cases not optimal for elderly patients. This has driven an increasing interest in noninvasive therapies for patients with CAVD. Adaptive immune cell signaling in the aortic valve has shown potential as a target for such a therapy. Up to 15% of cells in the healthy aortic valve are hematopoietic in origin, and these cells, which include macrophages, T lymphocytes, and B lymphocytes, are increased further in calcified specimens. Additionally, cytokine signaling has been shown to play a causative role in aortic valve calcification both in vitro and in vivo. This review summarizes the physiological presence of hematopoietic cells in the valve, innate and adaptive immune cell infiltration in disease states, and the cytokine signaling pathways that play a significant role in CAVD pathophysiology and may prove to be pharmaceutical targets for this disease in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 3×
“Naïve T cells mature into Th17 cells in the presence of transforming growth factor- (TGF- ) and IL-6, both of which are present in CAVD (45, 74, 81).”
BackgroundThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“In contrast, CD206 is a marker of M2 macrophages, which generally promote immunoregulation and long-term antibody production (108).”
Backgroundde Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308 · cited 1×
“Unfortunately, mice with PD-1 deficiency develop dilated cardiomyopathy and myocarditis (127, 169), which are only now starting to be seen in human patients taking the new therapies (75).”
BackgroundNahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Clinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029 · cited 1×
“Calcific aortic valve disease (CAVD) affects one of four people over 65 yr of age and is the primary cause of aortic stenosis (96, 164).”
BackgroundAutoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
T follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847 · cited 1×
“It is important to note here that in recent years there has been much more work done on the plasticity and heterogeneity of Th cell subtypes, as well as new subtypes altogether, such as T follicular helper cells (39).”
Background
Cited by
Driscoll, K., Cruz, A. D., & Butcher, J. T. (2021) · Circulation Research · doi:10.1161/circresaha.121.318011 · Cited by 102
Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis
Myasoedova, V. A., Massaiu, I., Moschetta, D., Chiesa, M., Songia, P., Valerio, V., Alfieri, V., Capoulade, R., Trabattoni, D., Andreini, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.747714 · Cited by 32
Lyu, T., Liu, Y., Li, B., Xu, R., Guo, J., & Zhu, D. (2023) · Biology Direct · doi:10.1186/s13062-023-00390-w · Cited by 18
“Currently, research has preliminarily revealed that the interaction between the resident cell population and infiltrating immnue cell population [9, 59] in the valve can promote the osteogenic differentiation of VICs, leading to valve leaflet calcification, thickening, and dysfunction [44].”
BackgroundMueller, K. A. L., Langnau, C., Harm, T., Sigle, M., Mott, K., Droppa, M., Borst, O., Rohlfing, A.-K., Gekeler, S., Günter, M., et al. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.124.321000 · Cited by 7
Tucureanu, M. M., Ciortan, L., Macarie, R. D., Mihaila, A. C., Droc, I., Butoi, E., & Manduteanu, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25053048 · Cited by 3
“Recent findings indicate that as much as 15% of cells in a healthy aortic valve have hematopoietic origins, comprising macrophages, T lymphocytes, and B lymphocytes, with their numbers further elevated in calcified valves [17].”
Background
Metadata
- Authors
- Raddatz, M. A., Madhur, M. S., & Merryman, W. D.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2019-07-01
- Volume
- 317
- Issue
- 1
- Pages
- H141-H155
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2942927046
- Cited by
- 91
- References
- 44
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adaptive immune cells in calcific aortic valve disease. https://app.cochat.ai/papers/10.1152/ajpheart.00100.2019
- The paper
- Raddatz, M. A., Madhur, M. S., & Merryman, W. D. (2019). Adaptive immune cells in calcific aortic valve disease. American Journal of Physiology-Heart and Circulatory Physiology. https://doi.org/10.1152/ajpheart.00100.2019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.